Knowridge Science Report1d
This drug shows long-term benefits for weight loss and diabetes prevention
A new study published in the New England Journal of Medicine suggests that tirzepatide, a medication originally developed for ...
Newspoint on MSN2d
Special injection 'Mounjaro' launched in India for people suffering from diabetes and obesity
Eli Lilly, a giant US pharma company, has launched its blockbuster drug for diabetes and obesity in India. The name of this ...
Prairie Public News3d
Patients scramble as cheaper obesity drug alternatives disappear
Compounding pharmacies have been allowed to essentially make a cheaper version of Eli Lilly's Zepbound, but they have to stop ...
Lexaria Bioscience Corp.: Lexaria's DehydraTECH-tirzepatide Oral Capsules Achieve Comparable Levels in Bloodstream as Eli Lilly's Injectable Zepbound
More consistent accumulation demonstrated in bloodstream over a one-week duration with once-daily DehydraTECH-tirzepatide oral capsules as compared to once-weekly injection of Zepbound®As previously a ...
Weighing the high cost of obesity reduction drugs
University of Chicago researchers assessed the long-term health outcomes and cost-effectiveness of four antiobesity ...
MarketBeat on MSN4d
Is Viking Therapeutics the Next Blockbuster GLP-1 Stock?
When it comes to clinical weight-loss treatments, GLP-1 therapies have taken the medical sector by storm. What started as off ...